• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕米膦酸盐成功治疗钙过敏症。

Successful treatment of calciphylaxis with pamidronate.

作者信息

Schliep Stefan, Schuler Gerold, Kiesewetter Franklin

机构信息

Department of dermatology and venerology, Universitätsklinikum Erlangen, Hartmannstr. 14, Erlangen, Germany.

出版信息

Eur J Dermatol. 2008 Sep-Oct;18(5):554-6. doi: 10.1684/ejd.2008.0499. Epub 2008 Aug 8.

DOI:10.1684/ejd.2008.0499
PMID:18693159
Abstract

Calciphylaxis is a rare syndrome characterized by calcification of blood vessels and panniculitis in association with ecchymosis and/or skin necrosis. Most commonly, calciphylaxis is seen in patients with chronic renal failure. In this context, bisphosphonates have been successfully applied in some patients. Here we report on a patient with calciphylaxis of unknown origin treated with pamidronate.

摘要

钙过敏是一种罕见的综合征,其特征为血管钙化和脂膜炎,并伴有瘀斑和/或皮肤坏死。最常见的是,钙过敏见于慢性肾衰竭患者。在此背景下,双膦酸盐已成功应用于一些患者。本文报告了一名使用帕米膦酸治疗的不明原因钙过敏患者。

相似文献

1
Successful treatment of calciphylaxis with pamidronate.帕米膦酸盐成功治疗钙过敏症。
Eur J Dermatol. 2008 Sep-Oct;18(5):554-6. doi: 10.1684/ejd.2008.0499. Epub 2008 Aug 8.
2
Low-dose tissue plasminogen activator for calciphylaxis.低剂量组织型纤溶酶原激活剂用于钙化防御。
Arch Dermatol. 2004 Sep;140(9):1045-8. doi: 10.1001/archderm.140.9.1045.
3
Pamidronate as a treatment option in calciphylaxis.帕米膦酸盐作为钙过敏的一种治疗选择。
J Eur Acad Dermatol Venereol. 2008 Sep;22(9):1128-30. doi: 10.1111/j.1468-3083.2007.02532.x. Epub 2007 Dec 7.
4
Benign nodular calcification and calciphylaxis in a haemodialysed patient.一名血液透析患者的良性结节性钙化和钙过敏症
J Eur Acad Dermatol Venereol. 1998 Jul;11(1):69-71.
5
Calciphylaxis responding to sodium thiosulfate therapy.对硫代硫酸钠治疗有反应的钙过敏症
Arch Dermatol. 2007 Feb;143(2):269-70. doi: 10.1001/archderm.143.2.269.
6
Cinacalcet for the treatment of calciphylaxis.
Arch Dermatol. 2007 Feb;143(2):152-4. doi: 10.1001/archderm.143.2.152.
7
Rapid improvement of calciphylaxis after intravenous pamidronate therapy in a patient with chronic renal failure.慢性肾衰竭患者静脉注射帕米膦酸二钠治疗后钙化防御迅速改善。
Nephrol Dial Transplant. 2004 Aug;19(8):2130-2. doi: 10.1093/ndt/gfh305.
8
Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates.双膦酸盐治疗钙化性尿毒症小动脉病所致顽固性伤口。
J Am Acad Dermatol. 2007 Dec;57(6):1021-5. doi: 10.1016/j.jaad.2007.06.029.
9
Unusual case of calciphylaxis associated with metastatic breast carcinoma.与转移性乳腺癌相关的钙化防御罕见病例。
Am J Dermatopathol. 2007 Aug;29(4):400-3. doi: 10.1097/DAD.0b013e3180ddb535.
10
Nonuraemic cutaneous calciphylaxis: our experience with a challenging disease.
Clin Exp Dermatol. 2020 Aug;45(6):745-746. doi: 10.1111/ced.14242. Epub 2020 May 18.

引用本文的文献

1
Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience.尿毒症性和非尿毒症性钙化防御的临床特征和治疗方式:一项皮肤科单中心经验。
Ren Fail. 2024 Dec;46(1):2297566. doi: 10.1080/0886022X.2023.2297566. Epub 2024 Jan 4.
2
Epidemiology and Treatment of Calcinosis Cutis: 13 Years of Experience.皮肤钙质沉着症的流行病学与治疗:13年经验总结
Indian J Dermatol. 2020 Mar-Apr;65(2):105-111. doi: 10.4103/ijd.IJD_527_18.
3
Non-uraemic calciphylaxis successfully treated with pamidronate infusion.
非尿毒症性钙磷沉积症经帕米膦酸二钠输注治疗后成功缓解。
Int Wound J. 2019 Feb;16(1):250-255. doi: 10.1111/iwj.13019. Epub 2018 Nov 4.
4
Gastrointestinal Bleeding Secondary to Calciphylaxis.钙化防御继发的胃肠道出血
Am J Case Rep. 2015 Nov 17;16:818-22. doi: 10.12659/ajcr.895164.
5
Raman spectroscopy for label-free identification of calciphylaxis.用于无标记识别钙过敏症的拉曼光谱法。
J Biomed Opt. 2015 Aug;20(8):80501. doi: 10.1117/1.JBO.20.8.080501.
6
Successful treatment of calciphylaxis by a multidisciplinary approach.采用多学科方法成功治疗钙过敏症。
BMJ Case Rep. 2014 Jul 17;2014:bcr2014204354. doi: 10.1136/bcr-2014-204354.
7
Nonuremic calciphylaxis precipitated by teriparatide [rhPTH(1-34)] therapy in the setting of chronic warfarin and glucocorticoid treatment.在慢性华法林和糖皮质激素治疗背景下,特立帕肽[重组人甲状旁腺激素(1-34)]治疗引发的非尿毒症性钙化防御。
Osteoporos Int. 2014 Apr;25(4):1411-4. doi: 10.1007/s00198-013-2580-6. Epub 2013 Nov 29.
8
Calcific uremic arteriolopathy on multimodal combination therapy: still unmet goal.多模式联合治疗钙化性尿毒症小动脉病:目标仍未达成
Int J Nephrol. 2012;2012:390768. doi: 10.1155/2012/390768. Epub 2012 Feb 20.
9
Calcific uremic arteriolopathy: an underrecognized entity.钙化性尿毒症性小动脉病:一种未被充分认识的疾病。
Perm J. 2011 Spring;15(2):85-7. doi: 10.7812/TPP/10-114.
10
[Analgesic therapy of calciphylaxis with levomethadone : a case study].
Schmerz. 2010 Dec;24(6):621-4. doi: 10.1007/s00482-010-0984-1.